Literature DB >> 6117090

Brain dopamine receptors.

P Seeman.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6117090

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  277 in total

1.  Characterization of [3H]nemonapride binding to mouse brain dopamine D2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies.

Authors:  K Ishiwata; K Inami; T Sasaki; T Nozaki; M Senda
Journal:  J Neural Transm Gen Sect       Date:  1994

2.  Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?

Authors:  K L Williamson; K J Broadley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs.

Authors:  L Castelletti; M Memo; C Missale; P F Spano; A Valerio
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

4.  Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment.

Authors:  H Higashi; K Inanaga; S Nishi; N Uchimura
Journal:  J Physiol       Date:  1989-01       Impact factor: 5.182

5.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.

Authors:  L Stinus; M Winnock; A E Kelley
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 7.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

8.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.

Authors:  A Campbell; R J Baldessarini; J L Neumeyer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Identification of novel catecholamine absorbing proteins in the central nervous system.

Authors:  G M Ross; B E McCarry; S Thakur; R K Mishra
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.